In lung cancer, the enforced PCDH7 expression significantly accelerates lung tumorigenesis in mice harboring the KrasG12D mutation and potentiates MAPK pathway activation (Zhou et al., 2017; Zhou et al., 2019). Here, PCDH7 is linked to lung cancer.